Cutaneous T-Cell Lymphoma in Adults

We diagnose cutaneous T-cell lymphoma, cancer of the white blood cells found in the skin, and provide personalized treatments based on the latest scientific research. Our oncologists, hematologists, and dermatologists work together to provide you with ongoing care and monitoring. Integrative medicine specialists, psycho-oncologists, and social workers are also available to provide the support you need while managing this condition.

Clinical Trials and Research Studies

Phase 3

A Phase 3 Randomized Multicenter Double-Blind Placebo-Controlled Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

Learn More

Phase 1

A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Learn More

Phase 2

A Phase 2 Trial of the Combination of Polatuzumab Vedotin Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma

Learn More

Phase 1

A Phase 1 Open-label Preliminary Pharmacokinetics (PK) and Safety Study of CLN-049 (An fms-like tyrosine kinase 3 [FLT3] x cluster of differentiation 3 [CD3] bispecific T cell engager) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Learn More